{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:36:21Z","timestamp":1770726981908,"version":"3.49.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Prolactinoma is the most common type of pituitary tumors, and its resultant tumor occupying and hormone disturbance greatly damage the health of patients. In this study, we investigated a protein kinase-PDZ Binding Kinase (PBK)\/T-LAK Cell-Originated Protein Kinase (TOPK) as a candidate protein regulating prolactin (PRL) secretion and tumor growth of prolactinomas.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Downloaded prolactinoma transcriptome dataset from Gene Expression Omnibus (GEO) database, and screened differentially expressed genes (DEGs) between normal pituitary tissues and prolactinoma tissues. Then, Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of DEGs were performed, a protein-protein interaction (PPI) network was constructed and the hub genes were identified. After a literature search, TOPK was presumed as an candidate target regulating the prolactinoma. We found a specific inhibitor of TOPK to investigate its effects on the proliferation, migration, apoptosis and PRL secretion of pituitary tumor cells. Finally, the regulation of TOPK inhibitor on its downstream target-p38 Mitogen Activated Protein Kinase (p38 MAPK) was detected to explore the potential mechanism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 361 DEGs were identified, and 20 hub genes were screened out. TOPK inhibitor HI-TOPK-032 could suppress the proliferation &amp;amp; migration and induce apoptosis of pituitary tumor cells <jats:italic>in vitro<\/jats:italic>, and reduce PRL secretion and tumor growth <jats:italic>in vivo<\/jats:italic>. HI-TOPK-032 also inhibited the phosphorylation level of the downstream target p38 MAPK, suggesting that TOPK inhibitors regulate the development of prolactinoma by mediating p38 MAPK.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study of identification and functional validation of TOPK suggests that this candidate can be a promising molecular target for prolactinoma treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.706909","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T11:41:42Z","timestamp":1642765302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["PBK\/TOPK Inhibitor Suppresses the Progression of Prolactinomas"],"prefix":"10.3389","volume":"12","author":[{"given":"Kejing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2014.11.003","article-title":"Prolactinomas","volume":"44","author":"Glezer","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1668","article-title":"High Prevalence of Pituitary Adenomas: A Cross-Sectional Study in the Province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of Pituitary Adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of Pituitary Adenomas: A Community-Based, Cross-Sectional Study in Banbury (Oxfordshire, Uk)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and Treatment of Pituitary Adenomas: A Review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-019-09534-8","article-title":"Aggressive Pituitary Tumors in the Young and Elderly","volume":"21","author":"Tatsi","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-019-09531-x","article-title":"Definition and Diagnosis of Aggressive Pituitary Tumors","volume":"21","author":"Kasuki","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0153-z","article-title":"Management of Aggressive Pituitary Adenomas: Current Treatment Strategies","volume":"12","author":"Buchfelder","year":"2009","journal-title":"Pituitary"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.568478","article-title":"Therapy of Aggressive Pituitary Tumors","volume":"12","author":"Colao","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11102-019-00987-3","article-title":"Dopamine Agonist Resistant Prolactinomas: Any Alternative Medical Treatment","volume":"23","author":"Souteiro","year":"2020","journal-title":"Pituitary"},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of Dopamine Agonist-Resistant Prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3207-05.2005","article-title":"PBK\/TOPK, a Proliferating Neural Progenitor-Specific Mitogen-Activated Protein Kinase Kinase","volume":"25","author":"Dougherty","year":"2005","journal-title":"J Neurosci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2003.10.004","article-title":"Protein Expression of PDZ-Binding Kinase is Up-Regulated in Hematologic Malignancies and Strongly Down-Regulated During Terminal Differentiation of HL-60 Leukemic Cells","volume":"32","author":"Nandi","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2002.1988","article-title":"Regulation of Growth-Related Genes by Interleukin-6 in Murine Myeloma Cells","volume":"20","author":"Cote","year":"2002","journal-title":"Cytokine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2001.0452","article-title":"PBK\/TOPK is a Novel Mitotic Kinase Which is Upregulated in Burkitt\u2019s Lymphoma and Other Highly Proliferative Malignant Cells","volume":"27","author":"Simons-Evelyn","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/ijms17071007","article-title":"PBK\/TOPK Expression Predicts Prognosis in Oral Cancer","volume":"17","author":"Chang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3851","article-title":"Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth","volume":"72","author":"Kim","year":"2012","journal-title":"Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.11.104","article-title":"TOPK Promotes Epithelial-Mesenchymal Transition and Invasion of Breast Cancer Cells Through Upregulation of TBX3 in TGF-Beta1\/Smad Signaling","volume":"522","author":"Lee","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12446","article-title":"Impact of a Novel Biomarker, T-LAK Cell-Originating Protein Kinase (TOPK) Expression on Outcome in Malignant Glioma","volume":"38","author":"Hayashi","year":"2018","journal-title":"Neuropathology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.10.068","article-title":"TOPK Mediates Hypoxia-Induced Epithelial-Mesenchymal Transition and the Invasion of Nonsmall-Cell Lung Cancer Cells via the HIF-1alpha\/Snail Axis","volume":"534","author":"Park","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41419-018-1131-7","article-title":"T-LAK Cell-Originated Protein Kinase (TOPK): An Emerging Target for Cancer-Specific Therapeutics","volume":"9","author":"Herbert","year":"2018","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M909629199","article-title":"Cloning and Expression of a Novel MAPKK-Like Protein Kinase, Lymphokine-Activated Killer T-Cell-Originated Protein Kinase, Specifically Expressed in the Testis and Activated Lymphoid Cells","volume":"275","author":"Abe","year":"2000","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15636","article-title":"Paeonol Suppresses Solar Ultraviolet-Induced Skin Inflammation by Targeting T-LAK Cell-Originated Protein Kinase","volume":"8","author":"Xue","year":"2017","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2174\/1871520619666190301123131","article-title":"Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK\/TOPK Protein Kinase","volume":"19","author":"Wang","year":"2019","journal-title":"Anticancer Agents Med Chem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12902-020-00619-z","article-title":"Inhibiting MAPK14 Showed Anti-Prolactinoma Effect","volume":"20","author":"Ding","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-015-0398-x","article-title":"Targeting PBK\/TOPK Decreases Growth and Survival of Glioma Initiating Cells In Vitro and Attenuates Tumor Growth In Vivo","volume":"14","author":"Joel","year":"2015","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0207","article-title":"T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer","volume":"22","author":"Ikeda","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2695","article-title":"Potent Anti-Myeloma Activity of the TOPK Inhibitor OTS514 in Pre-Clinical Models","volume":"9","author":"Stefka","year":"2020","journal-title":"Cancer Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30134","article-title":"PBK Promotes Aggressive Phenotypes of Cervical Cancer Through ERK\/c-Myc Signaling Pathway","volume":"236","author":"Ma","year":"2021","journal-title":"J Cell Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/75556","article-title":"Gene Ontology Consortium: Going Forward","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: Database for Annotation, Visualization, and Integrated Discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: A Database of Predicted Functional Associations Between Proteins","volume":"31","author":"von Mering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-01003-4","article-title":"Common Tools for Pituitary Adenomas Research: Cell Lines and Primary Cells","volume":"23","author":"Zhu","year":"2020","journal-title":"Pituitary"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1267\/ahc.14029","article-title":"A Histopathological Study of Multi-Hormone Producing Proliferative Lesions in Estrogen-Induced Rat Pituitary Prolactinoma","volume":"47","author":"Takekoshi","year":"2014","journal-title":"Acta Histochem Cytochem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000014618","article-title":"Pituitary Prolactin-Secreting Tumor Formation: Recent Developments","volume":"9","author":"Xu","year":"2000","journal-title":"Biol Signals Recept"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3107290","DOI":"10.1155\/2020\/3107290","article-title":"Antiprolactinoma Effect of Hordenine by Inhibiting MAPK Signaling Pathway Activation in Rats","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-082908-145957","article-title":"Applications of New Sequencing Technologies for Transcriptome Analysis","volume":"10","author":"Morozova","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: A Revolutionary Tool for Transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nat Rev Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: Archive for Functional Genomics Data Sets\u2013Update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28290","article-title":"Identification of Core Genes and Outcomes in Hepatocellular Carcinoma by Bioinformatics Analysis","volume":"120","author":"Shen","year":"2019","journal-title":"J Cell Biochem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"76S","DOI":"10.1177\/0963689719893950","article-title":"Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis","volume":"28","author":"Zhou","year":"2019","journal-title":"Cell Transplant"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210142","article-title":"PBK\/TOPK Promotes Tumour Cell Proliferation Through P38 MAPK Activity and Regulation of the DNA Damage Response","volume":"26","author":"Ayllon","year":"2007","journal-title":"Oncogene"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.3390\/cancers13092232","article-title":"PBK\/TOPK: An Effective Drug Target With Diverse Therapeutic Potential","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.090102397","article-title":"Characterization of PDZ-Binding Kinase, a Mitotic Kinase","volume":"97","author":"Gaudet","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.04.067","article-title":"A Mitotic Kinase TOPK Enhances Cdk1\/cyclin B1-Dependent Phosphorylation of PRC1 and Promotes Cytokinesis","volume":"370","author":"Abe","year":"2007","journal-title":"J Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"259ra145","DOI":"10.1126\/scitranslmed.3010277","article-title":"TOPK Inhibitor Induces Complete Tumor Regression in Xenograft Models of Human Cancer Through Inhibition of Cytokinesis","volume":"6","author":"Matsuo","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.706909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T11:41:45Z","timestamp":1642765305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.706909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":50,"alternative-id":["10.3389\/fendo.2021.706909"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.706909","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"article-number":"706909"}}